About 61% of patients with stage I or II dMMR colon cancer achieved a pathologic complete response after a single cycle of neoadjuvant pembrolizumab, new data revealed.
In a remarkable demonstration of medical expertise, CMRI Kolkata has successfully performed a highly intricate surgery on a patient of 72 years with a history of pancreatic cancer and hernia. | One of ...